Comparison in safety of chemotherapy protocols for blood cancers: toxicity of H-CVAD versus GELA/BURKIMAB/PETHEMA LAL

BACKGROUND AND OBJECTIVE: The Hyper-CVAD/Methotrexate-Cytarabine (H-CVAD/MTX-AraC) chemotherapy protocol has been one of the standard treatments for blood cancers, such as Mantle cell lymphoma (MCL), Burkitt’s lymphoma (BL) and B-cell and T-cell acute lymphoblastic leukaemia (ALL). Due to high toxic...

Descripción completa

Detalles Bibliográficos
Autores principales: Marín-Sánchez, Alberto, Martínez-Fernández, Gonzalo, Gómez-Catalán, Irene, Montoya-Morcillo, Mari Carmen, Algarra, Jesús Lorenzo, García, Ángela Ibañez, Hernández-Fernández, Francisco, Romero-Macías, Juan Ramón
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057780/
https://www.ncbi.nlm.nih.gov/pubmed/33912231
http://dx.doi.org/10.3332/ecancer.2021.1206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057780/
https://www.ncbi.nlm.nih.gov/pubmed/33912231
http://dx.doi.org/10.3332/ecancer.2021.1206

Ejemplares similares